The Ministry of Industry and Trade of the Russian Federation reports on the transfer of insulin analogue production technology to the Karaganda Pharmaceutical Complex from the 'Geropharm' company (St. Petersburg).
«In the presence of Deputy Prime Minister Denis Manturov, a ceremony took place for the signing of a long-term license agreement on granting the Karaganda Pharmaceutical Complex the right to use the secret of analog insulin production by the 'Geropharm' company and transfer of manufacturing technology», - writes the Ministry of Industry and Trade.
It is noted that the bottling and packaging stages will be localized at the Kazakhstan plant, and the first commercial product will be available by the end of 2024.